Product
Trientine
1 clinical trial
1 indication
Indication
Hypertrophic CardiomyopathyClinical trial
A Randomised, Double-blind, Placebo-controlled, Phase 2 Evaluation of the Efficacy and Mechanism of Trientine in Patients With Hypertrophic CardiomyopathyStatus: Active (not recruiting), Estimated PCD: 2024-04-30